Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
Stevanato Group S.p.A. Ordinary Shares (STVN)
Company Research
Source: Business Wire
New developments in the biopharmaceutical field fuel a need for highly scalable and flexible solutions PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled today two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill® Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC).This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240124439132/en/EZ-fill® Kit by Stevanato Group (Photo: Business Wire)In a context where reducing time-to-market is key, Stevanato Group’s new EZ-fill® Kit offers fast access to a customizable and versatile solution to pharma and biotech companies needing to efficiently fill small batches with high-quality injectable formulations during clinical trials or commercial ph
Show less
Read more
Impact Snapshot
Event Time:
STVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STVN alerts
High impacting Stevanato Group S.p.A. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
STVN
News
- Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire
- Stevanato Group (STVN) to Report Q1 Results: What You Should Expect [Yahoo! Finance]Yahoo! Finance
- Stevanato Group S.p.A. (NYSE: STVN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $30.00 price target on the stock.MarketBeat
- Stevanato Group S.p.A. (NYSE: STVN) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.MarketBeat
- Italy's Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices [BNN Bloomberg (Canada)]BNN Bloomberg
STVN
Earnings
- 3/7/24 - Miss
STVN
Sec Filings
- 3/27/24 - Form 6-K
- 3/26/24 - Form 6-K
- 3/25/24 - Form 6-K
- STVN's page on the SEC website